Literature DB >> 28889237

Analysis of clinical factors correlated with the accuracy of colposcopically directed biopsy.

Aiping Fan1, Liqin Zhang1, Chen Wang1, Yingmei Wang1, Cha Han1, Fengxia Xue2.   

Abstract

PURPOSE: Many factors affect the accuracy of colposcopically directed biopsy (CDB). This study aimed to compare the histological results of CDB with those of cone specimens and to determine clinical factors associated with the accuracy of CDB in defining the extent and severity of cervical intraepithelial neoplasia.
METHODS: We studied 513 patients diagnosed with cervical intraepithelial neoplasia by CDB who underwent conization between September 2012 and December 2016. We retrospectively evaluated the agreement between histological results on biopsies and cone specimens and analyzed factors influencing the accuracy of the results.
RESULTS: The overall agreement between the histological results on biopsy and the corresponding cone specimens was 74.1%; underestimation occurred in 6.4% of cases. The agreement between histological results on biopsy and cone specimen was 54.5% for low-grade lesions, 78.2% for high-grade lesions, and 28.9% for microinvasive cervical cancer. The overall agreement between high-grade cytology and the final histological diagnosis was 86.7%. By univariate analysis, patient age (p = 0.026), menopausal status (p = 0.018), type of transformation zone (p = 0.003), number of biopsies (p = 0.002), and cone width (p = 0.015) were found to be associated with the accuracy of CDB. However, multivariate logistic regression revealed that cone width (p = 0.044) was the only independent factor correlated with CDB accuracy.
CONCLUSIONS: Our data suggest that old age (≥50), postmenopausal status, and transformation zone type 3 might be positively associated with the under-diagnosis of CDB. Three or more biopsies and cone width ≥21 mm might improve CDB accuracy. However, cone width was the only independent factor correlated with CDB accuracy.

Entities:  

Keywords:  Accuracy; Cervical intraepithelial neoplasia; Clinical factors; Colposcopically directed biopsy; Conization

Mesh:

Year:  2017        PMID: 28889237     DOI: 10.1007/s00404-017-4500-z

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  6 in total

1.  Certification as dysplasia unit and its impact on large loop electrosurgical excision (LEEP).

Authors:  Tatjana Hanczuk; Martin Weiss; Leon Henes; Tobias Engler; Felix Neis; Melanie Henes
Journal:  Arch Gynecol Obstet       Date:  2022-10-08       Impact factor: 2.493

2.  Cervical Carcinoma: Evaluation Using Diffusion MRI With a Fractional Order Calculus Model and its Correlation With Histopathologic Findings.

Authors:  Xian Shao; Li An; Hui Liu; Hui Feng; Liyun Zheng; Yongming Dai; Bin Yu; Jin Zhang
Journal:  Front Oncol       Date:  2022-04-05       Impact factor: 5.738

3.  Assessing colposcopic accuracy for high-grade squamous intraepithelial lesion detection: a retrospective, cohort study.

Authors:  Anying Bai; Jiaxu Wang; Qing Li; Samuel Seery; Peng Xue; Yu Jiang
Journal:  BMC Womens Health       Date:  2022-01-11       Impact factor: 2.809

4.  Can biopsies be omitted after normal colposcopy in women referred with low-grade cervical cytology? A prospective cohort study.

Authors:  Mette Mindedahl Jespersen; Berit Bargum Booth; Lone Kjeld Petersen
Journal:  BMC Womens Health       Date:  2021-11-19       Impact factor: 2.809

5.  Optimizing the Detection of Occult Cervical Cancer: A Prospective Multicentre Study in China.

Authors:  Yanyun Li; Ying-Xin Gong; Qing Wang; Shujun Gao; Hongwei Zhang; Feng Xie; Qing Cong; Limei Chen; Qi Zhou; Zubei Hong; Lihua Qiu; Fang Li; Yu Xie; Long Sui
Journal:  Int J Womens Health       Date:  2021-10-27

6.  Improving colposcopic accuracy for cervical precancer detection: a retrospective multicenter study in China.

Authors:  Bingrui Wei; Bo Zhang; Peng Xue; Samuel Seery; Jiaxu Wang; Qing Li; Yu Jiang; Youlin Qiao
Journal:  BMC Cancer       Date:  2022-04-10       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.